Angelo Gámez‐Pozo

PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics

Angelo Gámez‐Pozo, Iker Sánchez‐Navarro, Enrique Calvo et al. · PLoS ONE · 2012 · 73 citations · Full text

Engineering, Pathology, Label-free Proteomics +19

MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients

Angelo Gámez‐Pozo, Luis Antón-Aparicio, Cristina Bayona et al. · Neoplasia · 2012 · 71 citations · Full text

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

Angelo Gámez‐Pozo, Julia Berges‐Soria, Jorge M. Arevalillo et al. · Cancer Research · 2015 · 68 citations · Full text

Clinical Implications, Unique Metabolic Profile, Engineering +20

Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues

Iker Sánchez‐Navarro, Angelo Gámez‐Pozo, Manuel González-Barón et al. · BioTechniques · 2010 · 66 citations · Full text

Breast Oncology, Engineering, Molecular Biology +17

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses

Guillermo Prado-Vázquez, Angelo Gámez‐Pozo, Lucía Trilla‐Fuertes et al. · Scientific Reports · 2019 · 62 citations · Full text